VIM and Hepatic fibrosis: Circulating levels of citrullinated and matrix metalloproteinases (MMP)-degraded vimentin (VICM) were increased in mouse liver tissues of hepatic fibrosis and in human liver tissues of early hepatic fibrosis associated with hepatitis c virus (HCV) and nonalcoholic fatty liver disease [20].